Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
06/2006
06/06/2006US7057027 primers/probes for amplification and detection of nucleic acids; for treatment of viral diseases
06/06/2006US7057026 Labelled nucleotides
06/06/2006US7056908 Containing indolecarbazole compounds, such as staurosporine.
06/06/2006US7056895 1-(3,4-dihydroxy-5-methylol-tetrahydrofur-2-yl),3-amidino-1H-1,2,4- triazoles; infections, infestations, autoimmune diseases; anticarcinogenic and -tumor agents; HIV, hepatitis C, human papilloma virus and giant cell arteritis
06/06/2006US7056894 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof
06/06/2006US7056666 Labeling a terminal monomer and scanning to determine the position; can analyze hundreds of macromolecules simultaneously
06/01/2006WO2006012078A3 Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
06/01/2006WO2005028481A8 Fused pentacyclic polyethers
06/01/2006DE102004056980A1 Verfahren zur ortsspezifischen Synthese von Biopolymeren auf festen Trägern A method for site-specific synthesis of biopolymers on solid supports
05/2006
05/31/2006EP1661905A1 Novel artificial nucleic acids of n-o bond crosslinkage type
05/31/2006EP1660511A2 Novel tricyclic nucleosides or nucleotides as therapeutic agents
05/31/2006EP1660510A1 Avermectins and avermectin monosaccharides substituted in the 4'- and 4'' position having pesticidal properties
05/31/2006EP1606233B1 Phospholipid esters of Clofarabin
05/31/2006CN1778809A Purification of 2-iodine-6-chlorine-9-beta(2',3',5'-trioxyacetyl-D-furanose) purine
05/31/2006CN1257912C Beta-L-2-deoxy-nucleosides for the treatment of hepatitis B
05/30/2006US7053207 L-ribo-LNA analogues
05/30/2006US7053199 triplexes/regulatory sequences for controlling gene expression; antisense agents; nuclease resistance
05/30/2006US7052876 generating DNA libraries having variable lengths and sequences comprising ligation of DNA molecules having receptivity to one another and are equivalent to the cleavage products of different but compatible restriction enzymes and cutting to desired orientation
05/30/2006US7052839 Detection of preferential nucleotide sequences in sample; obtain sample, incubate with amplification reaction mixture and label, expose to hydrolase, detect label
05/30/2006CA2165971C Methylphosphonic acid ester, process for preparing the same and its use
05/25/2006US20060111564 Photoactivatable two-stage protective groups for the synthesis of biopolymers
05/25/2006US20060111335 Photoactivated anti-viral and anti-cancer agent
05/25/2006US20060111311 caused by a flaviviridae family virus, such as hepatitis C virus; 4-amino-5-nitro-pyrrolo[2,3-d]pyrimidines
05/25/2006US20060111305 Metabolites of certain [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof
05/24/2006EP1658302A2 Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis c
05/24/2006EP1005573B1 Dendritic nucleic acids exhibiting maximal self-assembly
05/24/2006EP0813539B1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom
05/24/2006EP0804599B1 Mannose or xylose based positive selection
05/24/2006CN1777432A Anti-viral nucleoside analogs and methods for treating viral infections,especially HIV infections
05/24/2006CN1775795A Improved method for synthesizing PET developer labeled precursor thymidine derivative
05/24/2006CN1257177C Circular muscle glycoside diphosphoethoxymethyl ribose compound
05/23/2006US7049432 Oligonucleotides having alkylphosphonate linkages and methods for their preparation
05/23/2006US7049303 Inhibition of viruses
05/18/2006WO2005084653A3 Adenosine receptor agonists
05/18/2006US20060106197 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells
05/18/2006US20060105984 Chromium complex with insulin-like activity
05/18/2006US20060105971 such as 4''-deoxy-4''-epi-(N-isopropyl-N-methylamino)-avermectin B1, used for controlling plant pests
05/18/2006US20060105970 Avermectins substituted in the 4"-position having pesticidal properties
05/18/2006US20060105378 Tenascin-C nucleic acid ligands
05/18/2006US20060105337 Solid phase based nucleic acid assays combining high affinity and high specificity
05/17/2006EP1656093A2 Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses
05/17/2006EP0904275B1 Preparation of phosphorothioate oligomers
05/16/2006US7045617 Bisbubstrate inhibitors of kinases
05/16/2006US7045610 CONTAINING A 3-SUBSTITUTED PYRRAZOLO(,3,4-d) PYRIMIDINE
05/16/2006US7045547 Acyl-CoA dehydrogenase allenic inhibitors
05/16/2006US7045309 9-substituted adenine derivatives as prodrug regulators of cell and tissue function
05/16/2006US7045115 Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
05/11/2006WO2005084192A3 Novel 2’-c-methyl nucleoside derivatives
05/11/2006US20060100429 Alkynylpurine compounds and production methods thereof
05/11/2006US20060100169 Method to reduce an inflammatory response from arthritis
05/11/2006US20060100166 Compounds for modulating the activity of exchange proteins directly activated by camp (epacs)
05/10/2006EP1655381A1 Nucleic acid labeling methods
05/10/2006EP1655033A1 Nucleosides with anti-hepatitis B virus activity
05/10/2006EP1654270A1 Process for preparing 2',3'-didehydro-2',3'-dideoxynucleosides and 2',3'-dideoxynucleosides
05/10/2006EP1653976A1 Anti-viral nucleoside analogs and methods for treating viral infections, especially hiv infections
05/10/2006EP1334109B1 Improved synthesis of purine locked nucleic acid analogues
05/10/2006EP1255764B1 Purine derivatives
05/10/2006CN1771254A Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
05/10/2006CN1771253A Nucleotide lipid ester derivatives
05/10/2006CN1255422C Nucleosides
05/10/2006CN1255421C Process for preparation of L-ribavirin
05/10/2006CN1255420C Process for preparation of L-ribavirin
05/09/2006US7041812 Labeled nucleoside polyphosphates
05/09/2006US7041449 Determination of age in animals; obtain tissue sample from animal, monitor expression pattern of marker gene, compare to expression pattern in younger control, evaluate sample for aging
05/09/2006US7041446 Labeled protein and its producing method, labeling compound to be used in the method, and method for analyzing function of genes
05/04/2006US20060094870 Inosine derivatives and production methods therefor
05/04/2006US20060094869 Selective process for producing an anomer of a 1-phosphorylated saccharide derivative and process for producing a nucleoside
05/04/2006US20060094686 Use of corrinoids for application in skin diseases
05/04/2006US20060094685 Medicinal composition for drug-induced neuropathy
05/04/2006US20060094670 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases
05/04/2006CA2525358A1 Nucleic acid labeling methods
05/03/2006EP1652854A1 Indolopyrrolocabazole derivative and antitumor agent
05/03/2006EP1652852A1 Nucleoside capable of releasing functional unit through oxidation and process for producing oligonucleotide containing the same
05/03/2006EP1651658A1 Novel compounds having inhibitory activity against sodium-dependant transporter
05/03/2006EP1651342A2 Combinatorial synthesis on support
05/03/2006EP1651259A2 Methods and compositions for producing antigenic responses
05/03/2006CN1765913A 2úº-methoxy adenosine preparation method
05/02/2006US7038063 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis
05/02/2006US7038039 Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside
05/02/2006US7038038 Coupling silylated 5-azacytosine to a protected ribofuranose using trimethylsilyl trifluoromethane catalyst; cooling, accumulation by filtration, quenching, solvent extraction
05/02/2006US7038027 Reducing adjustments to synthetic nucleotide sequences; obtain sample nucleotide sequences, incubate with acrylonitrile scavanger and solvent, recover deprotected nucleotide sequences
05/02/2006US7038026 Isolating triplex DNA sequences using chromatographic, hybridization and separation investigations
05/02/2006US7037899 Derivatives of 2-3-O- isopropylidene- alpha -L-xylo-2-hexulofuranosonic acid, useful for treating inflammatory and autoimmune diseases
05/02/2006US7037718 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
05/02/2006US7037654 Methods and compositions for enhancing detection in determinations employing cleavable electrophoretic tag reagents
05/02/2006CA2184375C Oligonucleotide n3'-p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties
04/2006
04/27/2006WO2006010084A3 A system for delivering therapeutic agents into living cells and cell nuclei
04/27/2006WO2005118608A3 2’-nitrobenzyl-modified ribonucleotides
04/27/2006WO2005059157A3 METHODS AND COMPOSITIONS FOR USE IN PREPARING HAIRPIN RNAs
04/27/2006US20060089498 3-amino-2-ethoxycarbonylpyrrole; chemical intermediate in synthesis of 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one; a convergent synthesis route rather than a linear one
04/27/2006US20060089318 Inhibitors of adp-ribosyl transferases, cyclases, and hydrolases
04/27/2006US20060089313 Methods and compositions for ameliorating the undesirable effects of chemotherapy
04/27/2006US20060088877 Systematic evolution of ligands by exponential enrichment: Chemi-SELEX
04/27/2006DE102004051804A1 Beta-L-N4-Hydroxycytosin-Desoxynucleoside und ihre Verwendung als pharmazeutische Mittel zur Prophylaxe oder Therapie von viralen Erkrankungen Beta-L-N4-hydroxycytosine-deoxynucleosides and their use as pharmaceutical agents for the prophylaxis or therapy of viral diseases
04/27/2006CA2626363A1 Compositions and methods for prolonging survival of platelets
04/26/2006CN1763062A Flavin adenine dinucleotide disodium salt purification method
04/26/2006CN1253464C Ansi glycoside compound and its medicinal composition, preparation and use
04/26/2006CN1253463C Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same
04/25/2006US7034161 Process for producing a ribofuranose
04/25/2006US7034147 Drug screening for an agonist of a purine receptor, an antagonists; solid phase synthesis, comprising a tetrahydro-furo(3,4-d)(1,3)dioxol ring
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 201